Regulation and function of NF-kappaB transcription factors in the immune system.

The mammalian Rel/NF-kappaB family of transcription factors, including RelA, c-Rel, RelB, NF-kappaB1 (p50 and its precursor p105), and NF-kappaB2 (p52 and its precursor p100), plays a central role in the immune system by regulating several processes ranging from the development and survival of lymphocytes and lymphoid organs to the control of immune responses and malignant transformation. The five members of the NF-kappaB family are normally kept inactive in the cytoplasm by interaction with inhibitors called IkappaBs or the unprocessed forms of NF-kappaB1 and NF-kappaB2. A wide variety of signals emanating from antigen receptors, pattern-recognition receptors, receptors for the members of TNF and IL-1 cytokine families, and others induce differential activation of NF-kappaB heterodimers. Although work over the past two decades has shed significant light on the regulation of NF-kappaB transcription factors and their functions, much progress has been made in the past two years revealing new insights into the regulation and functions of NF-kappaB. This recent progress is covered in this review.

[1]  A. Mikecz The nuclear ubiquitin-proteasome system. , 2006 .

[2]  G. Baier,et al.  Protein Kinase C (cid:2) Affects Ca 2 (cid:3) Mobilization and NFAT Cell Activation in Primary Mouse T Cells , 2022 .

[3]  R. Wange,et al.  ZAP-70 and SLP-76 Regulate Protein Kinase C-θ and NF-κB Activation in Response to Engagement of CD3 and CD28 , 2001, The Journal of Immunology.

[4]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[5]  T. Nakahata,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only. , 2004 .

[6]  E. Kieff,et al.  Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Israël,et al.  Combined deficiency in IκBα and IκBϵ reveals a critical window of NF-κB activity in natural killer cell differentiation , 2004 .

[8]  S. Ghosh,et al.  Antigen-Receptor Signaling to Nuclear Factor κB , 2006 .

[9]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[10]  L. Staudt,et al.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. , 2007, Cancer cell.

[11]  Hong-shan Wang,et al.  BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells , 2002, Nature Immunology.

[12]  J. Ninomiya-Tsuji,et al.  The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.

[13]  M. Karin,et al.  IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiation , 2008, Proceedings of the National Academy of Sciences.

[14]  J. Ting,et al.  Cutting Edge: Monarch-1 Suppresses Non-Canonical NF-κB Activation and p52-Dependent Chemokine Expression in Monocytes1 , 2007, The Journal of Immunology.

[15]  R. Gaynor,et al.  Role of the TAB2‐related protein TAB3 in IL‐1 and TNF signaling , 2003, The EMBO journal.

[16]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[17]  E. Harhaj,et al.  NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .

[18]  P. Galle,et al.  Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD , 2007, The Journal of experimental medicine.

[19]  David Baltimore,et al.  Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.

[20]  A. Israël NF-κB activation: nondegradative ubiquitination implicates NEMO , 2006 .

[21]  M. Morimatsu,et al.  MAIL, a novel nuclear IκB protein that potentiates LPS‐induced IL‐6 production , 2000 .

[22]  A. Altman,et al.  Antigen-induced translocation of PKC-θ to membrane rafts is required for T cell activation , 2001, Nature Immunology.

[23]  J. Caamaño,et al.  Regulation of secondary lymphoid organ development by the nuclear factor‐κB signal transduction pathway , 2003, Immunological reviews.

[24]  A. Ciechanover,et al.  Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase , 2004, Oncogene.

[25]  Malay Mandal,et al.  Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia , 2007, Nature Medicine.

[26]  I. Wilson,et al.  Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Karin,et al.  The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .

[28]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[29]  T. Deerinck,et al.  Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .

[30]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[31]  S. Akira,et al.  Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ , 2004, Nature.

[32]  Xiaodong Wang,et al.  A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death , 2004, Science.

[33]  C. Wijmenga,et al.  The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes , 2003, Nature.

[34]  R. Geleziunas,et al.  Restoration of NF-κB Activation by Tumor Necrosis Factor Alpha Receptor Complex-Targeted MEKK3 in Receptor-Interacting Protein-Deficient Cells , 2004, Molecular and Cellular Biology.

[35]  T. Muta,et al.  Positive and Negative Regulation of Nuclear Factor-κB-mediated Transcription by IκB-ζ, an Inducible Nuclear Protein* , 2005, Journal of Biological Chemistry.

[36]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[37]  Brian D. Strahl,et al.  A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression , 2003, Nature.

[38]  David Baltimore,et al.  One Nucleotide in a κB Site Can Determine Cofactor Specificity for NF-κB Dimers , 2004, Cell.

[39]  R. Tibbetts,et al.  Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli , 2006, Science.

[40]  S. Klauck,et al.  Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti , 2000, Nature.

[41]  S. Ghosh,et al.  PDK1 Nucleates T Cell Receptor-Induced Signaling Complex for NF-κB Activation , 2005, Science.

[42]  J. Keats,et al.  Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling , 2008, Nature Immunology.

[43]  Georg Schett,et al.  IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss , 2005, The Journal of experimental medicine.

[44]  Ravi S. Misra,et al.  Caspase-8 and c-FLIPL Associate in Lipid Rafts with NF-κB Adaptors during T Cell Activation* , 2007, Journal of Biological Chemistry.

[45]  David Levens,et al.  Ribosomal Protein S3: A KH Domain Subunit in NF-κB Complexes that Mediates Selective Gene Regulation , 2007, Cell.

[46]  D. Raulet,et al.  Development and selection of γδ T cells , 2007 .

[47]  Zhijian J. Chen,et al.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.

[48]  F. Weih,et al.  Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen. , 2007, Blood.

[49]  J. Ruland,et al.  Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. , 2007, Blood.

[50]  L. del Peso,et al.  Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB* , 1999, The Journal of Biological Chemistry.

[51]  T. Deerinck,et al.  The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.

[52]  R. Medzhitov,et al.  Recognition of microbial infection by Toll-like receptors. , 2003, Current opinion in immunology.

[53]  D. Rawlings,et al.  Signaling in transitional type 2 B cells is critical for peripheral B‐cell development , 2004, Immunological reviews.

[54]  Mitchell Kronenberg,et al.  Toward an understanding of NKT cell biology: progress and paradoxes. , 2005, Annual review of immunology.

[55]  Honglin Zhou,et al.  Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. , 2005, Cancer cell.

[56]  David A. Cheresh,et al.  Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2007, Nature.

[57]  Shizuo Akira,et al.  Signaling to NF-?B by Toll-like receptors , 2007 .

[58]  Ji-Yeon Kim,et al.  Up-regulation of Cyclin D1 by HBx Is Mediated by NF-κB2/BCL3 Complex through κB Site of Cyclin D1 Promoter* , 2006, Journal of Biological Chemistry.

[59]  N. Copeland,et al.  The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20 , 2008, Nature Immunology.

[60]  F. Weih,et al.  Differential Requirement for Rel/Nuclear Factor κB Family Members in Natural Killer T Cell Development , 2003, The Journal of experimental medicine.

[61]  Jacques Neefjes,et al.  Translocation of PKCθ in T cells is mediated by a nonconventional, PI3-K– and Vav-dependent pathway, but does not absolutely require phospholipase C , 2002, The Journal of cell biology.

[62]  A. Weiss,et al.  The PI‐3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3 , 2003, Immunological reviews.

[63]  U. Siebenlist,et al.  Control of lymphocyte development by nuclear factor-κB , 2005, Nature Reviews Immunology.

[64]  H. Suyang,et al.  Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB , 1996 .

[65]  Vishva M. Dixit,et al.  IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis , 2007, Cell.

[66]  Noula Shembade,et al.  Essential role for TAX1BP1 in the termination of TNF‐α‐, IL‐1‐ and LPS‐mediated NF‐κB and JNK signaling , 2007 .

[67]  D. Pellicci,et al.  The Influence of CD1d in Postselection NKT Cell Maturation and Homeostasis1 , 2005, The Journal of Immunology.

[68]  A. Israël,et al.  Control of NF-κB Activity by the IκBβ Inhibitor , 1997 .

[69]  G. Bishop,et al.  Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. , 1997, Journal of immunology.

[70]  A. Baldwin,et al.  Members of the Nuclear Factor κB Family Transactivate the Murine c-myb Gene (*) , 1995, The Journal of Biological Chemistry.

[71]  M. Mayo,et al.  Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB , 2000, Molecular and Cellular Biology.

[72]  I. Verma,et al.  Immunological defects in mice with a targeted disruption in Bcl-3. , 1997, Genes & development.

[73]  Zhijian J. Chen,et al.  TRAF2: A Double-Edged Sword? , 2005, Science's STKE.

[74]  J. Tschopp,et al.  CARMA1 is a critical lipid raft–associated regulator of TCR-induced NF-κB activation , 2002, Nature Immunology.

[75]  K. Rajewsky,et al.  IκB Kinase Signaling Is Essential for Maintenance of Mature B Cells , 2002, The Journal of experimental medicine.

[76]  G. Nabel,et al.  A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription , 1997, Molecular and cellular biology.

[77]  D. Goeddel,et al.  TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. , 2002, Molecular cell.

[78]  T. Fujita,et al.  TIR-containing Adapter Molecule (TICAM)-2, a Bridging Adapter Recruiting to Toll-like Receptor 4 TICAM-1 That Induces Interferon-β* , 2003, Journal of Biological Chemistry.

[79]  F. Weih,et al.  RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF , 2003, The EMBO journal.

[80]  S. Ghosh,et al.  Characterization of the IκB-kinase NEMO Binding Domain* , 2002, The Journal of Biological Chemistry.

[81]  A. Israël,et al.  Deciphering the pathway from the TCR to NF-κB , 2006, Cell Death and Differentiation.

[82]  M. Mann,et al.  Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.

[83]  Jürgen Ruland,et al.  Transducing signals from antigen receptors to nuclear factor κB , 2003, Immunological reviews.

[84]  Ronald T. Hay,et al.  Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm , 1997 .

[85]  V. Bours,et al.  The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers , 1993, Cell.

[86]  F. Weih,et al.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.

[87]  M. Reitz,et al.  Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia , 1981, Nature.

[88]  D. F. Barber,et al.  NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. , 2000, Immunity.

[89]  J. Bertin,et al.  PYPAF7, a Novel PYRIN-containing Apaf1-like Protein That Regulates Activation of NF-κB and Caspase-1-dependent Cytokine Processing* , 2002, The Journal of Biological Chemistry.

[90]  M. Seto,et al.  Bcl10 and MALT1, Independent Targets of Chromosomal Translocation in MALT Lymphoma, Cooperate in a Novel NF-κB Signaling Pathway* , 2001, The Journal of Biological Chemistry.

[91]  G. Courtois,et al.  Mutations in the NF-κB signaling pathway: implications for human disease , 2006, Oncogene.

[92]  A. Shevchenko,et al.  Activation of Transcription Factor NF-κB Requires ELKS, an IκB Kinase Regulatory Subunit , 2004, Science.

[93]  L. Staudt,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[94]  T. Kaisho,et al.  PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit , 2007, Nature Immunology.

[95]  F. Weih,et al.  Inhibition of NF‐κB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice , 2001, European journal of immunology.

[96]  S. Akira,et al.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β , 2008, Nature Immunology.

[97]  G. Widhopf,et al.  Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. , 2006, Immunity.

[98]  Douglas R. McDonald,et al.  Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity , 2007, The Journal of experimental medicine.

[99]  E. Reinherz,et al.  Peptide-Induced Negative Selection of Thymocytes Activates Transcription of an NF-ΚB Inhibitor , 2002 .

[100]  Michael Karin,et al.  Intracellular pattern recognition receptors in the host response , 2006, Nature.

[101]  A. Israël,et al.  IκB proteins: structure, function and regulation , 1997 .

[102]  R. Gaynor,et al.  Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression , 2003, Nature.

[103]  Ryuji Kobayashi,et al.  IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a , 2004, Cell.

[104]  C. Geisler,et al.  Protein Kinase C (PKC)α and PKCθ Are the Major PKC Isotypes Involved in TCR Down-Regulation1 , 2006, The Journal of Immunology.

[105]  M. Rowe,et al.  Latent Membrane Protein 1 of Epstein-Barr Virus Stimulates Processing of NF-κB2 p100 to p52* , 2003, Journal of Biological Chemistry.

[106]  A. Israël,et al.  I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .

[107]  Zhijian J. Chen Ubiquitin signalling in the NF-κB pathway , 2005, Nature Cell Biology.

[108]  S. Srinivasula,et al.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation , 2006, Nature Cell Biology.

[109]  R. Hay,et al.  βTrCP-Mediated Proteolysis of NF-κB1 p105 Requires Phosphorylation of p105 Serines 927 and 932 , 2003, Molecular and Cellular Biology.

[110]  Michael U. Martin,et al.  Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. , 2002, Biochimica et biophysica acta.

[111]  C. Scheidereit,et al.  Shared Pathways of IκB Kinase-Induced SCFβTrCP-Mediated Ubiquitination and Degradation for the NF-κB Precursor p105 and IκBα , 2001, Molecular and Cellular Biology.

[112]  R. Carmody,et al.  Negative Regulation of Toll-Like Receptor Signaling by NF-κB p50 Ubiquitination Blockade , 2007, Science.

[113]  R. Germain T-cell development and the CD4–CD8 lineage decision , 2002, Nature Reviews Immunology.

[114]  J. Cyster,et al.  Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. , 2004, Immunity.

[115]  S. Akira,et al.  TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway , 2003, Nature Immunology.

[116]  M. Karin,et al.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. , 1993, Genes & development.

[117]  P. Farnham,et al.  T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. , 2004, Immunity.

[118]  Shao-Cong Sun,et al.  β-TrCP binding and processing of NF-κB2/p100 involve its phosphorylation at serines 866 and 870 , 2006 .

[119]  T. Hope,et al.  An N‐terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα , 1999 .

[120]  J. Ninomiya-Tsuji,et al.  IRAK-mediated Translocation of TRAF6 and TAB2 in the Interleukin-1-induced Activation of NFκB* , 2001, The Journal of Biological Chemistry.

[121]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[122]  Toby Lawrence,et al.  IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.

[123]  Zhaodan Cao,et al.  TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.

[124]  S. Ghosh,et al.  Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B , 1996, Molecular and cellular biology.

[125]  J. Knop,et al.  Effects of IL‐1 receptor‐associated kinase (IRAK) expression on IL‐1 signaling are independent of its kinase activity , 1999, FEBS letters.

[126]  Tak W. Mak,et al.  The role of nuclear factor-κB essential modulator (NEMO) in B cell development and survival , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[127]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[128]  Zhijian J. Chen,et al.  Ubiquitination and TRAF signaling. , 2007, Advances in experimental medicine and biology.

[129]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[130]  D. Lo,et al.  Expression of relB is required for the development of thymic medulla and dendritic cells , 1995, Nature.

[131]  N. Perkins Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway , 2006, Oncogene.

[132]  L. Scorrano,et al.  Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-κB and NFAT , 2001, Nature Immunology.

[133]  N. Gay,et al.  Structural Complementarity of Toll/Interleukin-1 Receptor Domains in Toll-like Receptors and the Adaptors Mal and MyD88* , 2003, Journal of Biological Chemistry.

[134]  O. Lantz,et al.  Lineage Relationships and Differentiation of Natural Killer (NK) T Cells: Intrathymic Selection and Interleukin (IL)-4 Production in the Absence of NKR-P1 and Ly49 Molecules , 1997, The Journal of experimental medicine.

[135]  H. Igarashi,et al.  Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. , 2005, International immunology.

[136]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[137]  M. Karin Nuclear factor-κB in cancer development and progression , 2006, Nature.

[138]  D. Goeddel,et al.  TNF-R1 Signaling: A Beautiful Pathway , 2002, Science.

[139]  Gabriel Pineda,et al.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.

[140]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[141]  Xiaojing Ma,et al.  Interferon Regulatory Factor 8 Regulates RANTES Gene Transcription in Cooperation with Interferon Regulatory Factor-1, NF-κB, and PU.1* , 2006, Journal of Biological Chemistry.

[142]  W. Liao,et al.  The essential role of MEKK3 in TNF-induced NF-κB activation , 2001, Nature Immunology.

[143]  L. Tong,et al.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains , 2000, Nature.

[144]  P. Lucas,et al.  A critical role of RICK/RIP2 polyubiquitination in Nod‐induced NF‐κB activation , 2008 .

[145]  M. Turner,et al.  The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[146]  I. Verma,et al.  Phosphorylation of SNAP-23 by IκB Kinase 2 Regulates Mast Cell Degranulation , 2008, Cell.

[147]  G. Cheng,et al.  Rescue of TRAF3-null mice by p100 NF-κB deficiency , 2006, The Journal of experimental medicine.

[148]  Ming-Qing Du,et al.  Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy , 2001, The Lancet.

[149]  B. Aronow,et al.  Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers , 2004 .

[150]  G. Courtois,et al.  Posttranslational modifications of NEMO and its partners in NF-κB signaling , 2006 .

[151]  J. Orange,et al.  Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations , 2002 .

[152]  M. Kelliher,et al.  The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. , 2000, Immunity.

[153]  Claus Scheidereit,et al.  NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.

[154]  L. Young,et al.  LMP1 structure and signal transduction. , 2001, Seminars in cancer biology.

[155]  F. Weih,et al.  RelB-Dependent Stromal Cells Promote T-Cell Leukemogenesis , 2008, PloS one.

[156]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.

[157]  B. Dörken,et al.  Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells , 1999, Oncogene.

[158]  V. Bours,et al.  The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. , 1993, The EMBO journal.

[159]  T. Serikawa,et al.  Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase , 1999, Nature Genetics.

[160]  B. Seed,et al.  RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis. , 1996, The EMBO journal.

[161]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[162]  Minoru Yoshida,et al.  A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes , 2000 .

[163]  A. Rabson,et al.  Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes , 2000, Oncogene.

[164]  Hana Kim,et al.  A Fourth IκB Protein within the NF-κB Signaling Module , 2007, Cell.

[165]  D. Baltimore,et al.  The NF‐kappa B p50 precursor, p105, contains an internal I kappa B‐like inhibitor that preferentially inhibits p50. , 1992, The EMBO journal.

[166]  D. Carrasco,et al.  Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-κB2 , 1997, The Journal of experimental medicine.

[167]  Albert Bendelac,et al.  The biology of NKT cells. , 2007, Annual review of immunology.

[168]  J. Pober,et al.  Tumor necrosis factor receptor-associated factors (TRAFs) , 2001, Oncogene.

[169]  D. Goeddel,et al.  The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis , 2003, The Journal of experimental medicine.

[170]  G. Hortobagyi,et al.  IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway , 2007, Cell.

[171]  Liming Yang,et al.  A loss-of-function RNA interference screen for molecular targets in cancer , 2006, Nature.

[172]  J. Inoue,et al.  Identification of TIFA as an Adapter Protein That Links Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) to Interleukin-1 (IL-1) Receptor-associated Kinase-1 (IRAK-1) in IL-1 Receptor Signaling* , 2003, The Journal of Biological Chemistry.

[173]  F. Martinon,et al.  RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation , 2004, Nature Immunology.

[174]  I. Screpanti,et al.  Notch3 and pre‐TCR interaction unveils distinct NF‐κB pathways in T‐cell development and leukemia , 2006, The EMBO journal.

[175]  David L. Vaux,et al.  IAPs, RINGs and ubiquitylation , 2005, Nature Reviews Molecular Cell Biology.

[176]  T. Mak,et al.  Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. , 2000, Genes & development.

[177]  E. Schaeffer,et al.  PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes , 2000, Nature.

[178]  Ramin Massoumi,et al.  Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling , 2006, Cell.

[179]  F. Weih,et al.  Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines1 , 2001, The Journal of Immunology.

[180]  D. Baltimore,et al.  The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[181]  J. Caamaño,et al.  Epstein–Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway , 2003, Oncogene.

[182]  Sokol Haxhinasto,et al.  Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)-deficient B Lymphocytes Reveal Novel Roles for TRAF2 in CD40 Signaling* , 2003, Journal of Biological Chemistry.

[183]  M. Neuenhahn,et al.  NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ , 2007, Cell.

[184]  D. Thomas,et al.  Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. , 1997, Journal of cell science.

[185]  A. Rao,et al.  Degradation of Bcl10 Induced by T-Cell Activation Negatively Regulates NF-κB Signaling , 2004, Molecular and Cellular Biology.

[186]  P. Evans,et al.  NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. , 2008, The Journal of biological chemistry.

[187]  V. Dötsch,et al.  Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins , 2008, Oncogene.

[188]  M. Busslinger Transcriptional control of early B cell development. , 2004, Annual review of immunology.

[189]  K. Todokoro,et al.  Isolation of a Novel Interleukin-1-inducible Nuclear Protein Bearing Ankyrin-repeat Motifs* , 2001, The Journal of Biological Chemistry.

[190]  L. Pham,et al.  Nuclear Localization in the Biology of the CD40 Receptor in Normal and Neoplastic Human B Lymphocytes* , 2006, Journal of Biological Chemistry.

[191]  M. Teitell,et al.  PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling , 2002, Nature Immunology.

[192]  X. Mao,et al.  COMMD1 promotes the ubiquitination of NF‐κB subunits through a cullin‐containing ubiquitin ligase , 2007, The EMBO journal.

[193]  F. Mackay,et al.  TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. , 2008, Immunity.

[194]  V. Godfrey,et al.  Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. , 2000, Molecular cell.

[195]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[196]  M. Busslinger,et al.  Pax5: the guardian of B cell identity and function , 2007, Nature Immunology.

[197]  David L. Vaux,et al.  IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis , 2007, Cell.

[198]  G. Bren,et al.  RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100* , 2002, The Journal of Biological Chemistry.

[199]  P. Dobrzanski,et al.  Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. , 1995, Oncogene.

[200]  K. Jeang,et al.  Coiled-coil motif as a structural basis for the interaction of HTLV type 1 Tax with cellular cofactors. , 2000, AIDS research and human retroviruses.

[201]  Yukio Nakamura,et al.  Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts , 1999, Oncogene.

[202]  C. Bakal,et al.  The Molecular Adapter Carma1 Controls Entry of IκB Kinase into the Central Immune Synapse , 2004, The Journal of experimental medicine.

[203]  Gabriel Núñez,et al.  Intracellular NOD-like receptors in host defense and disease. , 2007, Immunity.

[204]  R. Chaganti,et al.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50 , 1991, Cell.

[205]  G. Bishop The multifaceted roles of TRAFs in the regulation of B-cell function , 2004, Nature Reviews Immunology.

[206]  Michael Karin,et al.  Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.

[207]  David M. Rothwarf,et al.  The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus , 1999, Science's STKE.

[208]  Tom Maniatis,et al.  The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.

[209]  C. Turck,et al.  Akt-Dependent Phosphorylation Specifically Regulates Cot Induction of NF-κB-Dependent Transcription , 2002, Molecular and Cellular Biology.

[210]  B. Dörken,et al.  Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. , 1997, The Journal of clinical investigation.

[211]  Carey L. Medin,et al.  Functional Characterization of Murine Interferon Regulatory Factor 5 (IRF-5) and Its Role in the Innate Antiviral Response* , 2008, Journal of Biological Chemistry.

[212]  Zhijian J. Chen,et al.  The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. , 2004, Molecular cell.

[213]  Zhijian J. Chen,et al.  TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. , 2004, Molecular cell.

[214]  R. Beyaert,et al.  Yeast two-hybrid screening for proteins interacting with the anti-apoptotic protein A20. , 2004, Methods in molecular biology.

[215]  K. Ishii,et al.  Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling , 2006, Nature Immunology.

[216]  V. Diehl,et al.  Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells. , 2004, The Lancet. Oncology.

[217]  M. Karin,et al.  IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis , 2004, Nature.

[218]  H. Stein,et al.  Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas , 2005 .

[219]  John Bertin,et al.  Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.

[220]  S. Gaffen,et al.  CD3/CD28 Costimulation-Induced NF-κB Activation Is Mediated by Recruitment of Protein Kinase C-θ, Bcl10, and IκB Kinase β to the Immunological Synapse through CARMA1 , 2004, Molecular and Cellular Biology.

[221]  F. Weih,et al.  Mice lacking the transcription factor RelB develop T cell‐dependent skin lesions similar to human atopic dermatitis , 2000, European journal of immunology.

[222]  H. Erdjument-Bromage,et al.  IκB-β regulates the persistent response in a biphasic activation of NF-κB , 1995, Cell.

[223]  J. Hiscott Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. , 2007, Cytokine & growth factor reviews.

[224]  G. Bishop,et al.  Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. , 2007, Immunity.

[225]  J. Caamaño,et al.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo , 1996, Molecular and cellular biology.

[226]  A. Ashworth,et al.  CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.

[227]  R. Eisenberg,et al.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.

[228]  M. Merville,et al.  Protein Phosphorylation as a Key Mechanism for the Regulation of BCL-3 Activity , 2004, Cell cycle.

[229]  M. Busslinger,et al.  Lack of nuclear factor-kappa B2/p100 causes a RelB-dependent block in early B lymphopoiesis. , 2008, Blood.

[230]  Somasekar Seshagiri,et al.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.

[231]  P. Cohen,et al.  Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. , 2007, The Biochemical journal.

[232]  J. Bertin,et al.  Sensing intracellular pathogens-NOD-like receptors. , 2008, Current opinion in pharmacology.

[233]  J. Mizukami,et al.  TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways. , 2002, Biochemical and biophysical research communications.

[234]  G. Cheng,et al.  Control of canonical NF-κB activation through the NIK–IKK complex pathway , 2008, Proceedings of the National Academy of Sciences.

[235]  G. Mosialos,et al.  p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells , 1992, Journal of virology.

[236]  A. Israël,et al.  T-cell-receptor- and B-cell-receptor-mediated activation of NF-κB in lymphocytes , 2004 .

[237]  S. Westerheide,et al.  The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition , 2001, Molecular and Cellular Biology.

[238]  A. Duncan,et al.  Pleiotropic defects in TCR signaling in a Vav‐1‐null Jurkat T‐cell line , 2002, The EMBO journal.

[239]  Xiaolu Yang,et al.  Cellular Inhibitor of Apoptosis 1 and 2 Are Ubiquitin Ligases for the Apoptosis Inducer Smac/DIABLO* , 2003, The Journal of Biological Chemistry.

[240]  E. Harhaj,et al.  Retroviral oncoprotein Tax induces processing of NF‐κB2/p100 in T cells: evidence for the involvement of IKKα , 2001 .

[241]  A. Borsetti,et al.  Terminal Repeat Enhancer Immunodeficiency Virus Type 1 Long Transcriptional Activity at the Human B Κ Irf-1 Is Required for Full Nf , 2007 .

[242]  E. Cesarman,et al.  Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.

[243]  A. Israël,et al.  Induction of the NF-κB Cascade by Recruitment of the Scaffold Molecule NEMO to the T Cell Receptor , 2003 .

[244]  S. Akira,et al.  Essential function for the kinase TAK1 in innate and adaptive immune responses , 2005, Nature Immunology.

[245]  Michael Karin,et al.  Regulation and Function of IKK and IKK-Related Kinases , 2006, Science's STKE.

[246]  Zheng‐gang Liu,et al.  The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors , 2008, Nature Immunology.

[247]  G. Nolan,et al.  The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. , 1993, Genes & development.

[248]  I. Verma,et al.  Distinct roles of IκB proteins in regulating constitutive NF-κB activity , 2005, Nature Cell Biology.

[249]  Claus Scheidereit,et al.  IκB kinase complexes: gateways to NF-κB activation and transcription , 2006, Oncogene.

[250]  M. Mayo,et al.  IκB Kinase α-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300 , 2006, Molecular and Cellular Biology.

[251]  Z. Ye,et al.  ATP Binding by Monarch-1/NLRP12 Is Critical for Its Inhibitory Function , 2007, Molecular and Cellular Biology.

[252]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[253]  J. Ashwell,et al.  Lys63-Linked Polyubiquitination of IRAK-1 Is Required for Interleukin-1 Receptor- and Toll-Like Receptor-Mediated NF-κB Activation , 2008, Molecular and Cellular Biology.

[254]  B. Liu,et al.  Control of specificity and magnitude of NF-κB and STAT1-mediated gene activation through PIASy and PIAS1 cooperation , 2007, Proceedings of the National Academy of Sciences.

[255]  Honglin Zhou,et al.  Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.

[256]  S. Ley,et al.  Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .

[257]  G. Courtois,et al.  NF-κB Defects in Humans: The NEMO/Incontinentia Pigmenti Connection , 2000, Science's STKE.

[258]  G. Kroemer,et al.  Targeting NF-κB in hematologic malignancies , 2006, Cell Death and Differentiation.

[259]  B. Dörken,et al.  High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. , 1996, Blood.

[260]  M. Siekevitz,et al.  Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B. , 1992, The Journal of biological chemistry.

[261]  E. Schmidt,et al.  IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.

[262]  M. Xie,et al.  Persistent Activation of NF-κB by the Tax Transforming Protein Involves Chronic Phosphorylation of IκB Kinase Subunits IKKβ and IKKγ* , 2001, The Journal of Biological Chemistry.

[263]  R. Schmid,et al.  Rel/NF‐κB family member RelA regulates NK1.1− to NK1.1+ transition as well as IL‐15‐induced expansion of NKT cells , 2008, European journal of immunology.

[264]  D. Wallach,et al.  MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.

[265]  M. Schebesta,et al.  Transcriptional control of B-cell development. , 2002, Current opinion in immunology.

[266]  E. Harhaj,et al.  Regulation of the NF-κB-inducing Kinase by Tumor Necrosis Factor Receptor-associated Factor 3-induced Degradation* , 2004, Journal of Biological Chemistry.

[267]  T. Muta,et al.  Crucial roles of binding sites for NF-κB and C/EBPs in IκB-ζ-mediated transcriptional activation , 2007 .

[268]  Chun Chia Chen,et al.  Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-κB-induced CCAAT/enhancer-binding protein δ in mouse macrophages , 2006 .

[269]  Qiang Sun,et al.  The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways , 2007, Nature Immunology.

[270]  K. M. Bendt,et al.  LMP1 signaling and activation of NF-κB in LMP1 transgenic mice , 2006, Oncogene.

[271]  H. Kuwata,et al.  IkappaBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation. , 2006, Immunity.

[272]  A. Ryo,et al.  Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.

[273]  K. Irie,et al.  TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. , 2000, Molecular cell.

[274]  M. Karin,et al.  Essential Cytoplasmic Translocation of a Cytokine Receptor–Assembled Signaling Complex , 2008, Science.

[275]  Hiroshi Yasui,et al.  MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth In vitro and In vivo , 2006, Clinical Cancer Research.

[276]  F. Real,et al.  Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer , 2007, Proceedings of the National Academy of Sciences.

[277]  C. Ware,et al.  The unconventional role of LTαβ in T cell differentiation , 2007 .

[278]  G Cantarella,et al.  Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.

[279]  Steve Gerondakis,et al.  The anti‐apoptotic activities of Rel and RelA required during B‐cell maturation involve the regulation of Bcl‐2 expression , 2000, The EMBO journal.

[280]  C. Scheidereit,et al.  The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[281]  M. Teitell,et al.  Negative Regulation of NF-κB Signaling by PIAS1 , 2005, Molecular and Cellular Biology.

[282]  N. Gay,et al.  Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[283]  C. Hsieh,et al.  Regulation of LPS-mediated induction of C/EBPδ gene expression in livers of young and aged mice , 1998 .

[284]  C. Scheidereit,et al.  The NF‐kappa B precursor p105 and the proto‐oncogene product Bcl‐3 are I kappa B molecules and control nuclear translocation of NF‐kappa B. , 1993, The EMBO journal.

[285]  A. Shahangian,et al.  Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response , 2006, Nature.

[286]  D. Goeddel,et al.  Defective Lymphotoxin-β Receptor-Induced NF-κB Transcriptional Activity in NIK-Deficient Mice , 2001, Science.

[287]  Michael Karin,et al.  NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.

[288]  J. Skok,et al.  Transcriptional regulation in early B cell development. , 2007, Current opinion in immunology.

[289]  U. Lendahl,et al.  Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice , 2000, The EMBO journal.

[290]  L. Cantley,et al.  The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.

[291]  D. Green,et al.  The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .

[292]  C. Sedwick,et al.  Perspectives on PKCtheta in T cell activation. , 2004, Molecular immunology.

[293]  G. Natoli,et al.  Nuclear Ubiquitin Ligases, NF-κB Degradation, and the Control of Inflammation , 2008, Science Signaling.

[294]  B. Huhse,et al.  CD40 regulates the processing of NF‐κB2 p100 to p52 , 2002 .

[295]  K. Ebner,et al.  GMCSF activates NF-κB via direct interaction of the GMCSF receptor with IκB kinase β , 2003 .

[296]  A. Neri,et al.  Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators , 1995, Molecular and cellular biology.

[297]  W C Greene,et al.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.

[298]  David F. Kashatus,et al.  Expression of the Bcl-3 proto-oncogene suppresses p53 activation. , 2006, Genes & development.

[299]  M. Eby,et al.  The Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein Physically Associates with and Persistently Activates the IκB Kinase Complex* , 2002, The Journal of Biological Chemistry.

[300]  M. Matsumoto,et al.  Abnormal Immune Function of Hemopoietic Cells from Alymphoplasia (aly) Mice, a Natural Strain with Mutant NF-κB-Inducing Kinase1 , 2000, The Journal of Immunology.

[301]  G. Courtois,et al.  The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.

[302]  David Allman,et al.  Regulation of peripheral B cell maturation. , 2006, Cellular immunology.

[303]  R. Hay,et al.  Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα , 1999, Oncogene.

[304]  Eric Verdin,et al.  Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.

[305]  A. Hoffmann,et al.  Transcriptional regulation via the NF-κB signaling module , 2006, Oncogene.

[306]  A. Israël,et al.  NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. , 1996, Development.

[307]  M. Karin,et al.  ReviewMissing Pieces in the NF-B Puzzle stimulate the migration and maturation of lymphocytes , 2002 .

[308]  G. Cheng,et al.  Specificity of TRAF3 in Its Negative Regulation of the Noncanonical NF-κB Pathway* , 2006, Journal of Biological Chemistry.

[309]  L. Pham,et al.  Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma. , 2007, Blood.

[310]  M. Karin,et al.  IKKα controls formation of the epidermis independently of NF-κB , 2001, Nature.

[311]  S. Akira,et al.  The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[312]  T. Saitoh,et al.  TWEAK Induces NF-κB2 p100 Processing and Long Lasting NF-κB Activation* , 2003, Journal of Biological Chemistry.

[313]  T. Gilmore Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel , 1999, Oncogene.

[314]  Zhonghe Zhou,et al.  The smallest known non-avian theropod dinosaur , 2000, Nature.

[315]  T. Mak,et al.  Activation of noncanonical NF-κB requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, TRAF3 and the kinase NIK , 2008, Nature Immunology.

[316]  S. Gerondakis,et al.  Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.

[317]  Shizuo Akira,et al.  TIR domain-containing adaptors regulate TLR signaling pathways. , 2005, Advances in experimental medicine and biology.

[318]  M. Kehry,et al.  CD40 Signaling through Tumor Necrosis Factor Receptor-associated Factors (TRAFs) , 1999, The Journal of Biological Chemistry.

[319]  R. Gaynor,et al.  I-κB Kinases α and β Have Distinct Roles in Regulating Murine T Cell Function1 , 2002, The Journal of Immunology.

[320]  T. Banks,et al.  NIK-dependent RelB Activation Defines a Unique Signaling Pathway for the Development of Vα14i NKT Cells , 2003, The Journal of experimental medicine.

[321]  A. Hayday,et al.  Lymphotoxin-Mediated Regulation of γδ Cell Differentiation by αß T Cell Progenitors , 2005, Science.

[322]  L. Bruhn,et al.  Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. , 2007, Cancer cell.

[323]  T. Phan,et al.  Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. , 2004, Immunity.

[324]  R. Maehr,et al.  Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[325]  R. Brink,et al.  TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. , 2004, Immunity.

[326]  Michael D. Schneider,et al.  The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function , 2006, Nature Immunology.

[327]  Alexander Hoffmann,et al.  Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity , 2005, Science.